Joseph Lewis, 10% Owner, Director at Odonate Therapeutics, Inc. (ODT), bought 53,648 shares at $14.72 ($790K) on 2018-10-24, disclosed to the SEC on 2018-10-26.
Open-market purchase of $790k ODT by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.72 | 26,824 | $395K | 50.0% |
| 2 | $14.72 | 26,824 | $395K | 50.0% |
| Total | $14.72 avg | 53,648 | $790K | 100% |
| Filing → |
| MRTX | SELL | 2020-10-30 | $154.5M | — | Filing → |
| ODT | BUY | 2020-09-30 | $2.9M | — | Filing → |
| ODT | BUY | 2020-09-09 | $3.4M | — | Filing → |